ArticleFrontiers in pharmacology2022

Commentary: Pharmacological Validation of ASIC1a as a Druggable Target for Neuroprotection in Cerebral Ischemia Using an Intravenously Available Small Molecule Inhibitor.

Shreya Majagi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.